413 related articles for article (PubMed ID: 22111150)
1. Relocating abroad. FDA sends staff overseas to help monitor imports.
Lee J
Mod Healthc; 2011 Oct; 41(43):32. PubMed ID: 22111150
[No Abstract] [Full Text] [Related]
2. They are from the government and they really are here to help you.
Woosley RL
J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
[No Abstract] [Full Text] [Related]
3. Communicating with the FDA: the "third rail" of a new model for drug development.
Stanski DR; Orloff JJ
J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
[No Abstract] [Full Text] [Related]
4. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
[TBL] [Abstract][Full Text] [Related]
5. Product safety and business interests: deja vu..
Rijswijk L
Ostomy Wound Manage; 2005 Feb; 51(2):8-9. PubMed ID: 15699549
[No Abstract] [Full Text] [Related]
6. Change, but not in dollar bills. FDA needs more than money to fix problems: Congress.
Lubell J
Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18320666
[No Abstract] [Full Text] [Related]
7. The FDA's role in medical device clinical studies of human subjects.
Saviola J
J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
[TBL] [Abstract][Full Text] [Related]
8. Looking abroad: clinical drug trials.
Hathaway CR; Manthei JR; Haas JB; Scherer CA
Food Drug Law J; 2008; 63(3):673-81. PubMed ID: 19031667
[No Abstract] [Full Text] [Related]
9. Import for export; reporting and recordkeeping requirements for unapproved or violative products imported for further processing or incorporation and subsequent export--FDA. Proposed rule.
Fed Regist; 1998 Nov; 63(226):64930-7. PubMed ID: 10338872
[TBL] [Abstract][Full Text] [Related]
10. The FDA, preemption, and the Supreme Court.
Glantz LH; Annas GJ
N Engl J Med; 2008 May; 358(18):1883-5. PubMed ID: 18450601
[No Abstract] [Full Text] [Related]
11. Technology: drug and device export reform.
Betz R
J Healthc Resour Manag; 1995 Oct; 13(10):30, 33. PubMed ID: 10151686
[No Abstract] [Full Text] [Related]
12. FDA perspective on clinical trial design for cardiovascular devices.
Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
[No Abstract] [Full Text] [Related]
13. Combination products regulation at the FDA.
Lauritsen KJ; Nguyen T
Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
[TBL] [Abstract][Full Text] [Related]
14. New clinical trials policy at FDA.
Vastag B
Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
[No Abstract] [Full Text] [Related]
15. Trouble at the office.
Allison M
Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
[No Abstract] [Full Text] [Related]
16. Modernizing device regulation.
Garber AM
N Engl J Med; 2010 Apr; 362(13):1161-3. PubMed ID: 20335575
[No Abstract] [Full Text] [Related]
17. Medical research on humans: regulation in Switzerland, the European Union, and the United States.
Schott M
Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854
[No Abstract] [Full Text] [Related]
18. Administrative practices and procedures; internal agency review of decisions--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Sep; 63(184):50757. PubMed ID: 10185804
[TBL] [Abstract][Full Text] [Related]
19. Progress and deficiencies in the registration of clinical trials.
Wood AJ
N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628
[No Abstract] [Full Text] [Related]
20. FDA delays, unaccountability, raise health care costs and imperil American consumers' lives.
Lammi GG
Healthspan; 1995 Mar; 12(3):8-12. PubMed ID: 10166126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
